For years, gabapentinoids have enjoyed VIP status in multimodal pain protocols. They’ve been the “responsible adult” in the room — non-opioid, neuropathic pain–targeting, and generally well-tolerated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results